Towards Healthcare
Heartworm Treatment Products Market to Grow USD 2.85 Bn by 2034

Heartworm Treatment Products Market Rising with AI Adoption 2025

Based on market forecasts, the global heartworm treatment products market, projected at USD 1.45 billion in 2024, is expected to reach USD 2.85 billion by 2034, growing at a CAGR of 7.04% over the forecast period. The global market is propelled by the growing pet ownership and demand for awareness about heartworm treatments. The presence of well-developed veterinary infrastructure in North America is impacting its overall market expansion.

Content

  • Insight Code: 6108
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The heartworm treatment products market is valued at USD 1.55 billion in 2025 and is on track to reach USD 2.85 billion by 2034, witnessing a steady CAGR of 7.04% during the forecast span.

North America is currently leading the heartworm treatment products market share 44% due to a rise in pet ownership and robust veterinary infrastructure.

The heartworm treatment products market includes 5 segments such as by product type, by animal type, by distribution channel, by end user, and by region.

Some key players include Zoetis Inc., Elanco Animal Health, Boehringer Ingelheim Animal Health, and Merck Animal Health. 

Prevention and treatment are necessary because heartworm disease may result in severe damage to the pulmonary arteries and heart, which ultimately leads to right-sided heart failure and other serious difficulties.

US FDA, American Heartworm Society, NIH, CDC, DVM360, GOV.UK.
Any Questions